Consensus conference highlights treatment approaches for advanced prostate cancer in Japan, indicating global alignment and disparity.
The APCCC-JAPAN 2025 highlighted critical aspects of the current issues surrounding the management of advanced prostate cancer in Japan. Both similarities and differences were observed in the treatment approaches employed by Japanese urologists and global prostate cancer experts.
No takes yet. Share an insight, caveat, or question.
Inoue et al. (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: